‘‘(1) the procedures to establish accurate and 
efficient systems for the collection of gestational dia-
betes data within each State and commonwealth, 
territory, or possession of the United States; 
‘‘(2) the progress of collaborative activities with 
the National Vital Statistics System, the National 
Center for Health Statistics, and State health de-
partments with respect to the standard birth certifi-
cate, in order to improve surveillance of gestational 
diabetes; 
‘‘(3) postnatal methods of tracking women who 
had gestational diabetes after delivery as well as tar-
geted interventions proven to lower the incidence of 
type 2 diabetes in that population; 
‘‘(4) variations in the distribution of diagnosed 
and undiagnosed diabetes, and of impaired fasting 
glucose tolerance and impaired fasting glucose, with-
in and among groups of women; and 
‘‘(5) factors and culturally sensitive interven-
tions that influence risks and reduce the incidence of 
gestational diabetes during pregnancy and complica-
tions during childbirth, including cultural, behav-
ioral, racial, ethnic, geographic, demographic, socio-
economic, and genetic factors. 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
‘‘(d) MEETINGS.—Not later than 1 year after the es-
tablishment of the gestational diabetes research project 
under subsection (c), and annually thereafter, the Re-
search Advisory Committee shall meet to assess the 
progress of the project and to update the Secretary of 
Health and Human Services, if necessary. 
‘‘(e) REPORT.—Not later than 2 years after the date 
of the enactment of this title, and annually thereafter, the 
Director of the Centers for Disease Control and Preven-
tion shall generate a report on the prevalence and trends 
of gestational diabetes and disseminate the report to the 
Secretary of Health and Human Services and appropriate 
Federal and non-Federal agencies. 
‘‘SEC. 3302. DEMONSTRATION GRANTS TO LOWER THE RATE 
OF GESTATIONAL DIABETES DURING PREG-
NANCY. 
‘‘(a) IN GENERAL.—The Secretary of Health and 
Human Services, acting through the Director of the Cen-
ters for Disease Control and Prevention, in consultation 
with the Research Advisory Committee established under 
section 3301, shall award grants, on a competitive basis, 
to eligible entities for demonstration projects that build 
capacity with key stakeholders, build new surveillance sys-
tems, and implement and evaluate evidence-based inter-
ventions to reduce the incidence of gestational diabetes 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
and its recurrence and prevent type 2 diabetes after preg-
nancy. In making such grants, the Director give priority 
to projects focusing on— 
‘‘(1) helping women who have 1 or more risk 
factors for developing diabetes; 
‘‘(2) working with women who have had gesta-
tional diabetes during a previous pregnancy; 
‘‘(3) providing postnatal care for women who 
had gestational diabetes; 
‘‘(4) tracking cases where gestational diabetes 
led to the development of type 2 diabetes; 
‘‘(5) educating mothers about the increased risk 
of their child developing diabetes; 
‘‘(6) working to prevent or delay gestational di-
abetes and subsequent type 2 diabetes; and 
‘‘(7) achieving outcomes designed to assess effi-
cacy and cost-effectiveness of interventions that can 
inform decisions on long-term sustainability, includ-
ing third-party reimbursement. 
‘‘(b) APPLICATION.—An eligible entity desiring to re-
ceive a grant under this section shall submit to the Direc-
tor of the Centers for Disease Control and Prevention— 
‘‘(1) an application at such time, in such man-
ner, and containing such information as the Director 
may require; and 
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
‘‘(2) a plan to— 
‘‘(A) lower the rate of gestational diabetes 
during pregnancy; or 
‘‘(B) develop methods of tracking women 
who had gestational diabetes and develop effec-
tive interventions to lower the incidence of the 
recurrence of gestational diabetes and the devel-
opment of type 2 diabetes. 
‘‘(c) USES OF FUNDS.—An entity receiving a grant 
under this section shall use the grant funds to carry out 
demonstration projects that implement evidence-based 
interventions to reduce the incidence of gestational diabe-
tes and its recurrence, which may include— 
‘‘(1) expanding community-based health pro-
motion education, activities, and incentives focused 
on the prevention of gestational diabetes and type 2 
diabetes after pregnancy; 
‘‘(2) aiding State-based diabetes prevention and 
control programs to collect, analyze, disseminate, 
and report surveillance data on women with, and at 
risk for, gestational diabetes and its recurrence and 
prevention of type 2 diabetes after pregnancy; 
‘‘(3) building capacity with State-based part-
ners to implement programs and interventions to re-
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS
duce the occurrence of gestational diabetes based on 
surveillance data; and 
‘‘(4) training and encouraging health care pro-
viders— 
‘‘(A) to promote risk assessment, high- 
quality care, and self-management for gesta-
tional diabetes and its recurrence; and 
‘‘(B) to prevent type 2 diabetes after preg-
nancy and its complications in the practice set-
tings of the health care providers. 
‘‘(d) REPORTS.— 
‘‘(1) CDC REPORT.—Not later than 4 years 
after the date of the enactment of this title, the Di-
rector of the Centers for Disease Control and Pre-
vention shall prepare and submit a report to the 
Secretary of Health and Human Services concerning 
the results of the studies conducted through the 
grants awarded under this section. 
‘‘(2) SECRETARY REPORT.—Not later than 90 
days after receiving the report described in para-
graph (1), the Secretary shall prepare and submit a 
report to the Congress concerning the results and 
findings of the report. 
‘‘(e) DEFINITION OF ELIGIBLE ENTITY.—In this sec-
tion, the term ‘eligible entity’ means a nonprofit organiza-
VerDate Mar 15 2010 
21:39 May 21, 2010
Jkt 089200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.IH
H5354
hsrobinson on DSK69SOYB1PROD with BILLS